<- Go Home

Enzo Biochem, Inc.

Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally.

Market Cap

$52.8M

Volume

100.1K

Cash and Equivalents

$47.7M

EBITDA

-$9.2M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$13.5M

Profit Margin

44.39%

52 Week High

$1.50

52 Week Low

$0.93

Dividend

39.60%

Price / Book Value

N/A

Price / Earnings

-6.92

Price / Tangible Book Value

N/A

Enterprise Value

$8.3M

Enterprise Value / EBITDA

-0.96

Operating Income

-$10.5M

Return on Equity

-11.83%

Return on Assets

-7.24

Cash and Short Term Investments

$47.7M

Debt

$3.3M

Equity

$47.7M

Revenue

$30.3M

Unlevered FCF

-$227.4K

Sector

Health Care Providers and Services

Category

N/A

Company Stock Pitches